Phase I/II evaluation of effervescent and enteric coated oral pamidronate for bone metastases

Eur J Cancer. 1991;27(7):945-6. doi: 10.1016/0277-5379(91)90158-a.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / secondary*
  • Diphosphonates / administration & dosage
  • Drug Evaluation
  • Female
  • Humans
  • Middle Aged
  • Pamidronate
  • Tablets, Enteric-Coated

Substances

  • Diphosphonates
  • Tablets, Enteric-Coated
  • Pamidronate